MYCOPHENOLATE AND RIFAMPICIN (RIFAMPIN)
Rifampicin reduces the levels of mycophenolic acid (the active metabolite of mycophenolate) and increases the levels of the metabolite associated with mycophe- nolate adverse effects.
Mycophenolate should be monitored for efficacy and adverse effects if rifampicin is given and the dose adjusted as required, both on starting and stopping rifampicin.
Mycophenolate should be monitored for efficacy and adverse effects if rifampicin is given and the dose adjusted as required, both on starting and stopping rifampicin.